Citations (82)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Alex L Dubrava, Pan Su Pyae Kyaw, Joseph Newman, Jarrad Pringle, Justin Westhuyzen, Gina La Hera Fuentes, Thomas P Shakespeare, Renukadas Sakalkale & Noel J Aherne. (2023) Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?. Breast Cancer: Targets and Therapy 15, pages 359-371.
Read now
Read now
Jing Ma, Chao Dong, Yan-Zhen Cao & Bin-Lin Ma. (2023) Dual Target of EGFR and mTOR Suppresses Triple-Negative Breast Cancer Cell Growth by Regulating the Phosphorylation of mTOR Downstream Proteins. Breast Cancer: Targets and Therapy 15, pages 11-24.
Read now
Read now
Mehenaz Hanbazazh, Abdulhadi Samman, Saad Samargandy & Jaudah Al-Maghrabi. (2023) Prognostic value of glucose transporter proteins-1 (GLUT1) in breast carcinoma. Libyan Journal of Medicine 18:1.
Read now
Read now
John Hang Leung, Yun-Sheng Tai, Shyh-Yau Wang, Ho Tsung-Chin, Hei-Tung Yip Fion, Agnes LF Chan & Hsu Yu-Chen. (2023) Comparative Efficacy and safety of new targeted therapies and immunotherapies for metastatic triple negative breast cancer: a network meta-analysis. Expert Opinion on Drug Safety 22:3, pages 243-252.
Read now
Read now
Bing Jiang, Qian Liu, Junda Gai, Jingqian Guan & Qingchang Li. (2022) LncRNA SLC16A1-AS1 regulates the miR-182/PDCD4 axis and inhibits the triple-negative breast cancer cell cycle. Immunopharmacology and Immunotoxicology 44:4, pages 534-540.
Read now
Read now
Mehdi Roshanian Bakhsh, Maryam Peymani, Leila Rouhi & Kamran Ghaedi. (2022)
PSAT1 gene as a biomarker for targeting triple negative breast cancer in presence of Rapamycin. Nucleosides, Nucleotides & Nucleic Acids 41:2, pages 166-182.
Read now
Read now
Meghna Mehta, James Griffith, Janani Panneerselvam, Anish Babu, Jonathan Mani, Terence Herman, Rajagopal Ramesh & Anupama Munshi. (2021) Regorafenib sensitizes human breast cancer cells to radiation by inhibiting multiple kinases and inducing DNA damage. International Journal of Radiation Biology 97:8, pages 1109-1120.
Read now
Read now
Jiping Xie, Yi Wan, Min Zhang, Zeyu Jin & Yongqiang Yao. (2020) Circ_0061825 Acts as a miR-593-3p Sponge to Promote Breast Cancer Progression by Regulating FGFR3 Expression. Cancer Management and Research 12, pages 11243-11255.
Read now
Read now
Quanyi Long, Hongjiang Li, Yuan Fan & Jia Zhang. (2020) Overexpression of lncRNA TATDN1 Promotes Cancer Cell Proliferation in Triple Negative Breast Cancer by Regulating miR-26b Methylation. Cancer Management and Research 12, pages 11403-11410.
Read now
Read now
Hongliang Zang, Yuhui Li, Xue Zhang & Guomin Huang. (2020) Knockdown of circRAD18 Mitigates Breast Cancer Progression through the Regulation of miR-613/HK2 Axis. Cancer Management and Research 12, pages 3661-3672.
Read now
Read now
Shenglong Zhu, Lengyun Wei, Guangxiao Lin, Yuelin Tong, Jingwei Zhang, Xuan Jiang, Qingwen He, Xuyang Lu, Dou Dou Zhu & Yong Q. Chen. (2020) Metabolic Alterations Induced by Kudingcha Lead to Cancer Cell Apoptosis and Metastasis Inhibition. Nutrition and Cancer 72:4, pages 696-707.
Read now
Read now
Xian-Ling Qian, Yi-Hang Pan, Qi-Yuan Huang, Yu-Bo Shi, Qing-Yun Huang, Zhen-Zhen Hu & Li-Xia Xiong. (2019) Caveolin-1: a multifaceted driver of breast cancer progression and its application in clinical treatment. OncoTargets and Therapy 12, pages 1539-1552.
Read now
Read now
Jun Yang, Xuli Meng, Yong Yu, Lei Pan, Qinghui Zheng & Wei Lin. (2019) LncRNA POU3F3 promotes proliferation and inhibits apoptosis of cancer cells in triple-negative breast cancer by inactivating caspase 9. Bioscience, Biotechnology, and Biochemistry 83:6, pages 1117-1123.
Read now
Read now
Antonio Ieni, Valeria Barresi, Giuseppina Rosaria Rita Ricciardi, Barbara Adamo, Vincenzo Adamo & Giovanni Tuccari. (2016) Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al. Breast Cancer: Targets and Therapy 8, pages 157-159.
Read now
Read now
Articles from other publishers (68)
Anusha Shettigar, Rushigandha Salunke, Deepak Modi & Nupur Mukherjee. (2023) Targeting molecular cross-talk between tumor cells and tumor associated macrophage as therapeutic strategy in triple negative breast cancer. International Immunopharmacology 119, pages 110250.
Crossref
Crossref
Ran Ding, Qiwei Liu, Jing Yu, Yongkang Wang, Honglei Gao, Hongxing Kan & Yinfeng Yang. (2023) Identification of Breast Cancer Subtypes by Integrating Genomic Analysis with the Immune Microenvironment. ACS Omega 8:13, pages 12217-12231.
Crossref
Crossref
Supat Chupradit, Gunawan Widjaja, Basman Radhi Majeed, Maria Kuznetsova, Mohammad Javed Ansari, Wanich Suksatan, Abduladheem Turki Jalil & Bahar Ghazi Esfahani. (2022) Recent advances in cold atmospheric plasma (CAP) for breast cancer therapy. Cell Biology International 47:2, pages 327-340.
Crossref
Crossref
Anna Claudia M. Resende, Ernesto A. B. F. Lima, Regina C. Almeida, Matthew T. McKenna & Thomas E. Yankeelov. (2022) Model selection for assessing the effects of doxorubicin on triple-negative breast cancer cell lines. Journal of Mathematical Biology 85:6-7.
Crossref
Crossref
Chen Huang, Chunbin Li, Jiaxuan Cai, Jie Chen, Baobei Wang, Mengxia Li, Wei Zhou, Jianguo Wang, Pengfei Zhang & Jian V Zhang. (2022) Chondroitin Sulfate Targeting Nanodrug Achieves Near-Infrared Fluorescence-Guided Chemotherapy Against Triple-Negative Breast Primary and Lung Metastatic Cancer. International Journal of Nanomedicine Volume 17, pages 5547-5563.
Crossref
Crossref
Shuting Zuo, Jing Wang, Xianquan An, Zhenyu Wang, Xiao Zheng & Yan Zhang. (2022) Fabrication of Ginsenoside-Based Nanodrugs for Enhanced Antitumor Efficacy on Triple-Negative Breast Cancer. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Maycon Marção, Susanne Müller, Pedro Luiz P. Xavier & Tathiane M. Malta. (2022) Stemness inhibition by (+)-JQ1 in canine and human mammary cancer cells revealed by machine learning. Frontiers in Drug Discovery 2.
Crossref
Crossref
Erasmo Orrantia-Borunda, Patricia Anchondo-Nuñez, Lucero Evelia Acuña-Aguilar, Francisco Octavio Gómez-Valles & Claudia Adriana Ramírez-Valdespino. 2022. Breast Cancer. Breast Cancer
31
42
.
Elizabeth Brett, Michael Rosemann, Omid Azimzadeh, Andrea Pagani, Cosima Prahm, Adrien Daigeler, Dominik Duscher & Jonas Kolbenschlag. (2022) Irradiated Triple-Negative Breast Cancer Co-Culture Produces a Less Oncogenic Extracellular Matrix. International Journal of Molecular Sciences 23:15, pages 8265.
Crossref
Crossref
Gabriela Green-Tripp, Callum Nattress & Gunnel Halldén. (2022) Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Citra Dewi, Adryan Fristiohady, Riezki Amalia, Nur Kusaira Khairul Ikram, Sugeng Ibrahim & Muchtaridi Muchtaridi. (2022) Signaling Pathways and Natural Compounds in Triple-Negative Breast Cancer Cell Line. Molecules 27:12, pages 3661.
Crossref
Crossref
Ariana Acevedo-Díaz, Beatriz M. Morales-Cabán, Astrid Zayas-Santiago, Michelle M. Martínez-Montemayor & Ivette J. Suárez-Arroyo. (2022) SCAMP3 Regulates EGFR and Promotes Proliferation and Migration of Triple-Negative Breast Cancer Cells through the Modulation of AKT, ERK, and STAT3 Signaling Pathways. Cancers 14:11, pages 2807.
Crossref
Crossref
Killian Onwudiwe, John Obayemi, Jingjie Hu, Josephine Oparah, Chinyerem Onyekanne, Chukwudalu Nwazojie, Toyin Aina, Vanessa Uzonwanne, Ali Salifu & Winston Soboyejo. (2021)
Investigation of creep properties and the cytoskeletal structures of
non‐tumorigenic
breast cells and
triple‐negative
breast cancer cells
. Journal of Biomedical Materials Research Part A 110:5, pages 1004-1020.
Crossref
Crossref
Aiswarya Chaudhuri, Dulla Naveen Kumar, Deepa Dehari, Sanjay Singh, Pradeep Kumar, Pradeep Kumar Bolla, Dinesh Kumar & Ashish Kumar Agrawal. (2022) Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC). Pharmaceuticals 15:5, pages 542.
Crossref
Crossref
Nadia Benedetto, Luana Calabrone, Karolina Gutmańska, Nicoletta Macrì, Maria Grazia Cerrito, Riccardo Ricotta, Giuseppe Pelosi, Antonino Bruno, Douglas M. Noonan & Adriana Albini. (2022) An Olive Oil Mill Wastewater Extract Improves Chemotherapeutic Activity Against Breast Cancer Cells While Protecting From Cardiotoxicity. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Shengshan Xu, Yuchen Liu, Hansu Ma, Shuo Fang, Shoupeng Wei, Xiaoping Li, Zhuming Lu, Youbin Zheng, Tong Liu, Xiaojian Zhu, Dongming Xu & Yihang Pan. (2022) A Novel Signature Integrated of Immunoglobulin, Glycosylation and Anti-Viral Genes to Predict Prognosis for Breast Cancer. Frontiers in Genetics 13.
Crossref
Crossref
Vivian Hui, Rachel Brazee, Margaret Rosenzweig & Young Ji Lee. (2022) The Association Between Hormone Receptor Status and End-of-Life Care Among Patients With Metastatic Breast Cancer. Clinical Journal of Oncology Nursing 26:2, pages 198-203.
Crossref
Crossref
Jiefeng Zhou, Qingcao Li, Haoran Wu, Shin-Han Tsai & Yu-Ting Yeh. (2022) Effective Inhibition of Mitochondrial Metabolism by Cryptotanshinone in
MDA-MB231 cells: A Proteomic Analysis. Current Proteomics 19:1, pages 20-29.
Crossref
Crossref
Phuong Linh Nguyen, Chang Hoon Lee, Heesoon Lee & Jungsook Cho. (2022) Induction of Paraptotic Cell Death in Breast Cancer Cells by a Novel Pyrazolo[3,4-h]quinoline Derivative through ROS Production and Endoplasmic Reticulum Stress. Antioxidants 11:1, pages 117.
Crossref
Crossref
Rizka Vinkan Septiani, Widyanti Soewoto & Ida Bagus Budhi. (2022) Chemotherapy Effect on Estradiol Levels in Patients with Triple-negative Breast Cancer: A Clinical Prospective Study from Indonesia. Open Access Macedonian Journal of Medical Sciences 10:B, pages 477-481.
Crossref
Crossref
Juan Alberto Serrano Olvera, Diego Osorio Pérez, Alejandro Noguez Ramos, Raúl Gerardo Ramírez Medina, Adriana Jiménez Cantero & Luis Fernando Manríquez Cedillo de la Borbolla. (2022) Aspectos clínicos y terapéuticos del carcinoma de mama metastásico triple negativo. Anales Médicos de la Asociación Médica del Centro Médico ABC 67:2, pages 119-130.
Crossref
Crossref
Iago Dillion Lima CavalcantiIago Dillion Lima Cavalcanti. 2022. Chemotherapy Protocols and Infusion Sequence. Chemotherapy Protocols and Infusion Sequence
79
123
.
Stella C. Ogbu, Samuel Rojas, John Weaver, Phillip R. Musich, Jinyu Zhang, Zhi Q. Yao & Yong Jiang. (2021) DSTYK Enhances Chemoresistance in Triple-Negative Breast Cancer Cells. Cells 11:1, pages 97.
Crossref
Crossref
Fu-Ying Qin, Te Xu, Yan-Peng Li, Hao-Xing Zhang, Dan Cai, Li-Zhong Liu & Yong-Xian Cheng. (2021) Terminal Cyclohexane-Type Meroterpenoids from the Fruiting Bodies of Ganoderma cochlear. Frontiers in Chemistry 9.
Crossref
Crossref
Radu Vidra, Adina Nemes, Andreea Vidrean, Sebastian Pintea, Snejeana Tintari, Andrada Deac & Tudor Ciuleanu. (2021) Pathological complete response following cisplatin or carboplatin‑based neoadjuvant chemotherapy for triple‑negative breast cancer: A systematic review and meta‑analysis. Experimental and Therapeutic Medicine 23:1.
Crossref
Crossref
Rayanah Barnawi, Samiyah Al-Khaldi, Salma Majid, Amal Qattan, Tala Bakheet, Mohannad Fallatah, Hazem Ghebeh, Nehad M. Alajez & Monther Al-Alwan. (2021) Comprehensive Transcriptome and Pathway Analyses Revealed Central Role for Fascin in Promoting Triple-Negative Breast Cancer Progression. Pharmaceuticals 14:12, pages 1228.
Crossref
Crossref
Chia-Che Chang, Chien-Chih Chiu, Pei-Feng Liu, Chih-Hsuan Wu, Yen-Chiang Tseng, Cheng-Hsin Lee & Chih-Wen Shu. (2021) Kinome-Wide siRNA Screening Identifies DYRK1B as a Potential Therapeutic Target for Triple-Negative Breast Cancer Cells. Cancers 13:22, pages 5779.
Crossref
Crossref
Yue Li, Yong Zhou, Miaoran Wang, Xiaojing Lin, Yunqi Zhang, Irakoze Laurent, Ying Zhong & Jibin Li. (2021) Ampelopsin Inhibits Breast Cancer Cell Growth through Mitochondrial Apoptosis Pathway. Biological and Pharmaceutical Bulletin 44:11, pages 1738-1745.
Crossref
Crossref
Ana Paço, Joana Leitão-Castro & Renata Freitas. (2021) Epigenetic Regulation of CDH1 Is Altered after HOXB7-Silencing in MDA-MB-468 Triple-Negative Breast Cancer Cells. Genes 12:10, pages 1575.
Crossref
Crossref
Weipeng Zhao, Xichuan Li, Weiqi Nian, Jun Wang, Xiaorui Wang, Linlin Sun, Ye Zhu & Zhongsheng Tong. (2021) Ribosome Proteins Represented by RPL27A Mark the Development and Metastasis of Triple-Negative Breast Cancer in Mouse and Human. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Kitti Andreidesz, Aliz Szabo, Dominika Kovacs, Balazs Koszegi, Viola Bagone Vantus, Eszter Vamos, Mostafa Isbera, Tamas Kalai, Zita Bognar, Krisztina Kovacs & Ferenc Gallyas. (2021) Cytostatic Effect of a Novel Mitochondria-Targeted Pyrroline Nitroxide in Human Breast Cancer Lines. International Journal of Molecular Sciences 22:16, pages 9016.
Crossref
Crossref
Emma Rodriguez, Guangsheng Pei, Zhongming Zhao, Sang Kim, Alexis German & Prema Robinson. (2021) Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis. Cancers 13:15, pages 3871.
Crossref
Crossref
Jeremy Johnson, Zeta Chow, Eun Lee, Heidi L. Weiss, B. Mark Evers & Piotr Rychahou. (2021) Role of AMPK and Akt in triple negative breast cancer lung colonization. Neoplasia 23:4, pages 429-438.
Crossref
Crossref
Wenchao Gu, Ryan Yudistiro, Hirofumi Hanaoka, Natsumi Katsumata & Yoshito Tsushima. (2021) Potential of three-step pretargeting radioimmunotherapy using biotinylated bevacizumab and succinylated streptavidin in triple-negative breast cancer xenograft. Annals of Nuclear Medicine 35:4, pages 514-522.
Crossref
Crossref
Fengliang Wang, Sujin Yang, Mingming Lv, Fei Chen, Hong Yin, Sheng Gao, Jinhai Tang & Jing Yu. (2021) Novel Long Noncoding RNA 005620 Induces Epirubicin Resistance in Triple-Negative Breast Cancer by Regulating ITGB1 Expression. Frontiers in Oncology 11.
Crossref
Crossref
Cho-Long Kim, Yu-Su Shin, Sue-Hee Choi, Seroc Oh, Kyeongseob Kim, Han-Sol Jeong & Jung-Soon Mo. (2021) Extracts of Perilla frutescens var. Acuta (Odash.) Kudo Leaves Have Antitumor Effects on Breast Cancer Cells by Suppressing YAP Activity. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-13.
Crossref
Crossref
Diana Tavares-Valente, Bárbara Sousa, Fernando Schmitt, Fátima Baltazar & Odília Queirós. (2021) Disruption of pH Dynamics Suppresses Proliferation and Potentiates Doxorubicin Cytotoxicity in Breast Cancer Cells. Pharmaceutics 13:2, pages 242.
Crossref
Crossref
Megan N. Dang, Carolina Gomez Casas & Emily S. Day. (2020) Photoresponsive miR-34a/Nanoshell Conjugates Enable Light-Triggered Gene Regulation to Impair the Function of Triple-Negative Breast Cancer Cells. Nano Letters 21:1, pages 68-76.
Crossref
Crossref
Anita Sejben, András Vörös, Arbel Golan, Tamás Zombori & Gábor Cserni. (2021) The Added Value of SOX10 Immunohistochemistry to Other Breast Markers in Identifying Cytokeratin 5-Positive Triple Negative Breast Cancers as of Mammary Origin. Pathobiology 88:3, pages 228-233.
Crossref
Crossref
Kanchan Chauhan, Prakhar Sengar, Karla Juarez-Moreno, Gustavo A. Hirata & Rafael Vazquez-Duhalt. (2020) Camouflaged, activatable and therapeutic tandem bionanoreactors for breast cancer theranosis. Journal of Colloid and Interface Science 580, pages 365-376.
Crossref
Crossref
Mamta Kumari, Praveen T. Krishnamurthy, Sai kiran S. S. PinduproluPiyongsola Sola. (2020) DR-5 and DLL-4 mAb Functionalized SLNs of Gamma-Secretase Inhibitors- An Approach for TNBC Treatment. Advanced Pharmaceutical Bulletin 11:4, pages 618-623.
Crossref
Crossref
Juan Xu, Kang-jing Wu, Qiao-jun Jia & Xian-feng Ding. (2020) Roles of miRNA and IncRNA in triple-negative breast cancermiRNA 和 lncRNA在三阴性乳腺癌中的作用. Journal of Zhejiang University-SCIENCE B 21:9, pages 673-689.
Crossref
Crossref
Young Hwa Soung, Heesung Chung, Cecilia Yan, Andrew Fesler, Hyungjin Kim, Eok-Soo Oh, Jingfang Ju & Jun Chung. (2020) Therapeutic Potential of Chemically Modified miR-489 in Triple-Negative Breast Cancers. Cancers 12:8, pages 2209.
Crossref
Crossref
Arvand Asghari & Michihisa Umetani. (2020) Obesity and Cancer: 27-Hydroxycholesterol, the Missing Link. International Journal of Molecular Sciences 21:14, pages 4822.
Crossref
Crossref
Ke Wang, Xue Zhu & Yongxiang Yin. (2020) Maslinic Acid Enhances Docetaxel Response in Human Docetaxel-Resistant Triple Negative Breast Carcinoma MDA-MB-231 Cells via Regulating MELK-FoxM1-ABCB1 Signaling Cascade. Frontiers in Pharmacology 11.
Crossref
Crossref
Jin Sun Lee, Susan E. Yost & Yuan Yuan. (2020) Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges. Cancers 12:6, pages 1404.
Crossref
Crossref
Jeremy Johnson, Zeta Chow, Dana Napier, Eun Lee, Heidi L. Weiss, B. Mark Evers & Piotr Rychahou. (2020) Targeting PI3K and AMPKα Signaling Alone or in Combination to Enhance Radiosensitivity of Triple Negative Breast Cancer. Cells 9:5, pages 1253.
Crossref
Crossref
Kyu-Shik Lee, Min-Gu Lee, Yun-Suk Kwon & Kyung-Soo Nam. (2020) Arctigenin Enhances the Cytotoxic Effect of Doxorubicin in MDA-MB-231 Breast Cancer Cells. International Journal of Molecular Sciences 21:8, pages 2997.
Crossref
Crossref
Defan Yao, Yanshu Wang, Rongfeng Zou, Kexin Bian, Pei Liu, Shuzhan Shen, Weitao Yang, Bingbo Zhang & Dengbin Wang. (2020) Molecular Engineered Squaraine Nanoprobe for NIR-II/Photoacoustic Imaging and Photothermal Therapy of Metastatic Breast Cancer. ACS Applied Materials & Interfaces 12:4, pages 4276-4284.
Crossref
Crossref
Isidora TošićN.N., Momir MikovM.M. & Karmen StankovM.M.. (2020) Application of nanomedical technology in breast cancer treatment. Hospital Pharmacology - International Multidisciplinary Journal 7:1, pages 883-894.
Crossref
Crossref
Christopher Nguyen, Kiruthika Baskaran, Alaina Pupulin, Ivan Ruvinov, Ola Zaitoon, Sahibjot Grewal, Benjamin Scaria, Ali Mehaidli, Caleb Vegh & Siyaram Pandey. (2019) Hibiscus flower extract selectively induces apoptosis in breast cancer cells and positively interacts with common chemotherapeutics. BMC Complementary and Alternative Medicine 19:1.
Crossref
Crossref
Asmaa Reda, Alaa Refaat, Ahmed A. Abd-Rabou, Ali Mokhtar Mahmoud, Mohamed Adel, Salwa Sabet & Sameh Saad Ali. (2019) Role of mitochondria in rescuing glycolytically inhibited subpopulation of triple negative but not hormone-responsive breast cancer cells. Scientific Reports 9:1.
Crossref
Crossref
Jan Dominik Kuhlmann, Hagen Sjard Bachmann, Theresa Link, Pauline Wimberger, Eric Kröber, Christoph Thomssen, Brahima Mallé, Daniel Bethmann, Martina Vetter & Eva Johanna Kantelhardt. (2019) Association of caspase 8 polymorphisms -652 6N InsDel and Asp302His with progression-free survival and tumor infiltrating lymphocytes in early breast cancer. Scientific Reports 9:1.
Crossref
Crossref
Olorunseun O. Ogunwobi & Adithya Kumar. (2019) Chemoresistance Mediated by ceRNA Networks Associated With the PVT1 Locus. Frontiers in Oncology 9.
Crossref
Crossref
Silvia Cecilia Pacheco-Velázquez, Juan Carlos Gallardo-Pérez, Daniel Díaz, Alhelí Adán-Ladrón de Guevara, Diana Xochiquetzal Robledo-Cadena, Emma Saavedra, Luz Ruiz-Godoy, Luis Roberto Jimenez-Hernández, Jesús Vargas-Barrón, José Luis Aguilar-Ponce & Sara Rodríguez-Enríquez. (2019) Heart myxoma develops oncogenic and metastatic phenotype. Journal of Cancer Research and Clinical Oncology 145:5, pages 1283-1295.
Crossref
Crossref
Natalia Riobo-Del Galdo, Ángela Lara Montero & Eva Wertheimer. (2019) Role of Hedgehog Signaling in Breast Cancer: Pathogenesis and Therapeutics. Cells 8:4, pages 375.
Crossref
Crossref
Mariateresa Badolato, Gabriele Carullo, Maria Cristina Caroleo, Erika Cione, Francesca Aiello & Fabrizio Manetti. (2019) Discovery of 1,4-Naphthoquinones as a New Class of Antiproliferative Agents Targeting GPR55. ACS Medicinal Chemistry Letters 10:4, pages 402-406.
Crossref
Crossref
Hanieh Hossein-Nejad-Ariani, Emad Althagafi & Kamaljit Kaur. (2019) Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells. Scientific Reports 9:1.
Crossref
Crossref
Elizabeth Varghese, Samson Samuel, Sharon Varghese, Sohaila Cheema, Ravinder Mamtani & Dietrich Büsselberg. (2018) Triptolide Decreases Cell Proliferation and Induces Cell Death in Triple Negative MDA-MB-231 Breast Cancer Cells. Biomolecules 8:4, pages 163.
Crossref
Crossref
Vishak Raman, Uma K. Aryal, Victoria Hedrick, Rodrigo Mohallem Ferreira, Jorge Luis Fuentes Lorenzo, Elena E. Stashenko, Morris Levy, Maria M. Levy & Ignacio G. Camarillo. (2018)
Proteomic Analysis Reveals That an Extract of the Plant
Lippia origanoides
Suppresses Mitochondrial Metabolism in Triple-Negative Breast Cancer Cells
. Journal of Proteome Research 17:10, pages 3370-3383.
Crossref
Crossref
Sandra L. Romero-Cordoba, Sergio Rodriguez-Cuevas, Veronica Bautista-Pina, Antonio Maffuz-Aziz, Elvira D’Ippolito, Giulia Cosentino, Sara Baroni, Marilena V. Iorio & Alfredo Hidalgo-Miranda. (2018) Loss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic metabolic reprogramming in triple negative breast cancer. Scientific Reports 8:1.
Crossref
Crossref
Ryan Yudistiro, Hirofumi Hanaoka, Natsumi Katsumata, Aiko Yamaguchi & Yoshito Tsushima. (2018) Bevacizumab Radioimmunotherapy (RIT) with Accelerated Blood Clearance Using the Avidin Chase. Molecular Pharmaceutics 15:6, pages 2165-2173.
Crossref
Crossref
Ewelina Piktel, Izabela Prokop, Urszula Wnorowska, Grzegorz Król, Mateusz Cieśluk, Katarzyna Niemirowicz, Paul B. Savage & Robert Bucki. (2018) Ceragenin CSA-13 as free molecules and attached to magnetic nanoparticle surfaces induce caspase-dependent apoptosis in human breast cancer cells via disruption of cell oxidative balance. Oncotarget 9:31, pages 21904-21920.
Crossref
Crossref
Selcen ARI. (2018) Meme Kanser Kök Hücrelerinde Notch Sinyal Yolağının İnhibisyonunda Güncel YaklaşımlarRecent Applications in Inhibition of Notch Signalling Pathway on Breast Cancer Stem Cell. Marmara Fen Bilimleri Dergisi 30:1, pages 94-104.
Crossref
Crossref
Jeffrey A. Thompson, Brock C. Christensen & Carmen J. Marsit. (2018) Methylation-to-Expression Feature Models of Breast Cancer Accurately Predict Overall Survival, Distant-Recurrence Free Survival, and Pathologic Complete Response in Multiple Cohorts. Scientific Reports 8:1.
Crossref
Crossref
Sarah Shields, Emer Conroy, Tony O’Grady, Alo McGoldrick, Kate Connor, Mark P. Ward, Zivile Useckaite, Eugene Dempsey, Rebecca Reilly, Yue Fan, Anthony Chubb, David Gomez Matallanas, Elaine W. Kay, Darran O’Connor, Amanda McCann, William M. Gallagher & Judith A. Coppinger. (2018) BAG3 promotes tumour cell proliferation by regulating EGFR signal transduction pathways in triple negative breast cancer. Oncotarget 9:21, pages 15673-15690.
Crossref
Crossref
Hyo Jang, Martin Pearce, Edmond O’Donnell, Bach Nguyen, Lisa Truong, Monica Mueller, William Bisson, Nancy Kerkvliet, Robert Tanguay & Siva Kolluri. (2017) Identification of a Raloxifene Analog That Promotes AhR-Mediated Apoptosis in Cancer Cells. Biology 6:4, pages 41.
Crossref
Crossref
Song Park, Yonghun Sung, Jain Jeong, Minjee Choi, Jinhee Lee, Wookbong Kwon, Soyoung Jang, Si Jun Park, Hyeng-Soo Kim, Mee-Hyun Lee, Dong Joon Kim, Kangdong Liu, Sung-Hyun Kim, Zigang Dong, Zae Young Ryoo & Myoung Ok Kim. (2017) hMAGEA2 promotes progression of breast cancer by regulating Akt and Erk1/2 pathways. Oncotarget 8:23, pages 37115-37127.
Crossref
Crossref